CHRNA10 | Cholinergic receptor, nicotinic, alpha 10 (neuronal) | FDA approved drug targets Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
RAPSN | Receptor-associated protein of the synapse | Cytoskeleton related proteins Disease related genes
| | | | | Tissue enriched |
CHRND | Cholinergic receptor, nicotinic, delta (muscle) | Disease related genes Potential drug targets Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Tissue enriched |
KLHL41 | Kelch-like family member 41 | Cytoskeleton related proteins Plasma proteins
| | | | | Tissue enriched |
SYPL2 | Synaptophysin-like 2 | Predicted membrane proteins
| | | | | Tissue enriched |
TRIM72 | Tripartite motif containing 72 | | | | | | Tissue enriched |
AMPD1 | Adenosine monophosphate deaminase 1 | Disease related genes Enzymes Potential drug targets Predicted secreted proteins
| | | | | Tissue enriched |
FHL3 | Four and a half LIM domains 3 | | | | | | Tissue enriched |
CA3 | Carbonic anhydrase III, muscle specific | Enzymes FDA approved drug targets Plasma proteins
| | | | | Tissue enriched |
LRRC30 | Leucine rich repeat containing 30 | | | | | | Tissue enriched |
MYF6 | Myogenic factor 6 (herculin) | Disease related genes Transcription factors
| | | | | Tissue enriched |
TMEM38A | Transmembrane protein 38A | Predicted membrane proteins
| | | | | Tissue enriched |
VGLL2 | Vestigial like 2 (Drosophila) | | | | | | Tissue enriched |
ASB16 | Ankyrin repeat and SOCS box containing 16 | | | | | | Tissue enriched |
KLHL34 | Kelch-like family member 34 | | | | | | Tissue enriched |
KLHL40 | Kelch-like family member 40 | Disease related genes
| | | | | Tissue enriched |
MSS51 | MSS51 mitochondrial translational activator | | | | | | Tissue enriched |
MYOZ3 | Myozenin 3 | | | | | | Tissue enriched |
CALML6 | Calmodulin-like 6 | RAS pathway related proteins
| | | | | Tissue enriched |
ATP1B4 | ATPase, Na+/K+ transporting, beta 4 polypeptide | Predicted membrane proteins
| | | | | Tissue enriched |
ENO3 | Enolase 3 (beta, muscle) | Candidate cardiovascular disease genes Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Tissue enriched |
LSMEM1 | Leucine-rich single-pass membrane protein 1 | Predicted membrane proteins
| | | | | Tissue enriched |
MUSTN1 | Musculoskeletal, embryonic nuclear protein 1 | | | | | | Tissue enriched |
PHKG1 | Phosphorylase kinase, gamma 1 (muscle) | Enzymes Predicted membrane proteins
| | | | | Tissue enriched |
SLN | Sarcolipin | Predicted membrane proteins Transporters
| | | | | Tissue enriched |
TNNT1 | Troponin T type 1 (skeletal, slow) | Disease related genes
| | | | | Tissue enriched |
ASB10 | Ankyrin repeat and SOCS box containing 10 | Disease related genes
| | | | | Tissue enriched |
FBP2 | Fructose-1,6-bisphosphatase 2 | Enzymes Plasma proteins
| | | | | Tissue enriched |
PLCD4 | Phospholipase C, delta 4 | Enzymes
| | | | | Tissue enriched |
RTN2 | Reticulon 2 | Disease related genes Predicted membrane proteins
| | | | | Tissue enriched |
BIN1 | Bridging integrator 1 | Disease related genes
| | | | | Tissue enriched |
MAPK12 | Mitogen-activated protein kinase 12 | Disease related genes Enzymes Mitochondrial proteins Potential drug targets
| | | | | Tissue enriched |
MYOD1 | Myogenic differentiation 1 | Cancer-related genes Transcription factors
| | | | | Tissue enriched |
MYOG | Myogenin (myogenic factor 4) | Cancer-related genes Plasma proteins Transcription factors
| | | | | Tissue enriched |
PITX3 | Paired-like homeodomain 3 | Disease related genes Transcription factors
| | | | | Tissue enriched |
RGS9BP | Regulator of G protein signaling 9 binding protein | Disease related genes Predicted membrane proteins
| | | | | Tissue enriched |
RXRG | Retinoid X receptor, gamma | Cancer-related genes FDA approved drug targets Nuclear receptors Plasma proteins Transcription factors
| | | | | Tissue enriched |
CKM | Creatine kinase, muscle | Candidate cardiovascular disease genes Enzymes FDA approved drug targets Plasma proteins
| | | | | Tissue enriched |
RP11-155D18.14 | Poly(rC)-binding protein 4 | | | | | | Tissue enriched |
TPM2 | Tropomyosin 2 (beta) | Cancer-related genes Disease related genes Plasma proteins
| | | | | Tissue enriched |
ACHE | Acetylcholinesterase (Yt blood group) | Blood group antigen proteins Enzymes FDA approved drug targets Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
ACTA1 | Actin, alpha 1, skeletal muscle | Cytoskeleton related proteins Disease related genes Plasma proteins
| | | | | Tissue enriched |
CACNB1 | Calcium channel, voltage-dependent, beta 1 subunit | FDA approved drug targets
| | | | | Tissue enriched |
DDIT4L | DNA-damage-inducible transcript 4-like | | | | | | Tissue enriched |
DUSP13 | Dual specificity phosphatase 13 | Enzymes Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
KCNJ11 | Potassium inwardly-rectifying channel, subfamily J, member 11 | Disease related genes FDA approved drug targets Predicted membrane proteins Voltage-gated ion channels
| | | | | Tissue enriched |
KCNJ12 | Potassium inwardly-rectifying channel, subfamily J, member 12 | FDA approved drug targets Predicted membrane proteins Voltage-gated ion channels
| | | | | Tissue enriched |
MN1 | Meningioma (disrupted in balanced translocation) 1 | Cancer-related genes Disease related genes
| | | | | Tissue enriched |
NOS1 | Nitric oxide synthase 1 (neuronal) | Cancer-related genes Cytoskeleton related proteins Enzymes Plasma proteins
| | | | | Tissue enriched |
OBSCN | Obscurin, cytoskeletal calmodulin and titin-interacting RhoGEF | Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Tissue enriched |